The upregulation of specific MMPs, like MMP-1, -2, -3, and -7, in intestinal inflammation and IBD implicates not only their contribution to the development of CAC but also their potential as biomarkers to identify increasing dysplasia and incipient neoplasia. This evidence concerns the gene MMP1 and inflammatory bowel disease.